U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C29H21FN3O4.Na
Molecular Weight 517.4829
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CR-3465

SMILES

[Na+].[O-]C(=O)[C@H](CC1=CC=C(OCC2=NC3=CC(F)=CC=C3C=C2)C=C1)NC(=O)C4=NC5=CC=CC=C5C=C4

InChI

InChIKey=KGZGMOFDZSCICN-YCBFMBTMSA-M
InChI=1S/C29H22FN3O4.Na/c30-21-10-7-20-8-11-22(31-26(20)16-21)17-37-23-12-5-18(6-13-23)15-27(29(35)36)33-28(34)25-14-9-19-3-1-2-4-24(19)32-25;/h1-14,16,27H,15,17H2,(H,33,34)(H,35,36);/q;+1/p-1/t27-;/m0./s1

HIDE SMILES / InChI

Molecular Formula C29H21FN3O4
Molecular Weight 494.4931
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 18:07:33 GMT 2023
Edited
by admin
on Sat Dec 16 18:07:33 GMT 2023
Record UNII
5DC7F7S5N7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CR-3465
Common Name English
CR3465
Code English
(2S)-3-(4-((7-FLUORO-2-QUINOLYL)METHOXY)PHENYL)-2-(QUINOLINE-2-CARBONYLAMINO)PROPANOIC ACID SODIUM HYDRIDE
Systematic Name English
L-TYROSINE, O-((7-FLUORO-2-QUINOLINYL)METHYL)-N-(2-QUINOLINYLCARBONYL)-, SODIUM SALT (1:1)
Systematic Name English
Code System Code Type Description
ChEMBL
CHEMBL3545273
Created by admin on Sat Dec 16 18:07:33 GMT 2023 , Edited by admin on Sat Dec 16 18:07:33 GMT 2023
PRIMARY
PUBCHEM
71474171
Created by admin on Sat Dec 16 18:07:33 GMT 2023 , Edited by admin on Sat Dec 16 18:07:33 GMT 2023
PRIMARY
CAS
1448619-70-2
Created by admin on Sat Dec 16 18:07:33 GMT 2023 , Edited by admin on Sat Dec 16 18:07:33 GMT 2023
PRIMARY
FDA UNII
5DC7F7S5N7
Created by admin on Sat Dec 16 18:07:33 GMT 2023 , Edited by admin on Sat Dec 16 18:07:33 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
Intravenous (i.v.) administration of the agent both antagonized (ED50, 9.9+/-1.9 microg/kg) and reverted LTD4 -induced bronchoconstriction of anesthetized guinea pigs. CR3465 reduced inflammatory infiltrates in the bronchoalveolar lavage fluid after antigen challenge of sensitized animals, and proved also active in inhibiting phosphodiesterase 3 (PDE3) and phosphodiesterase 4 (PDE4) activities exhibited by human platelets and neutrophils (IC50, 2.01+/-0.07 and 4.7+/-0.5 microM). In line with properties shown by phosphodiesterase inhibitors, CR3465 reduced the contractile response of guinea pig airways to histamine and decreased N-formyl-Met-Leu-Phe (fMLP)-induced degranulation of human neutrophils (IC50, 13.8 microM).Pharmacokinetic data in the rat demonstrated approximately 100% bioavailability of the agent.